Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hivello x Banxa - $HVLO Token Available via Apple Pay & Credit Card
-
Hivello x Banxa - $HVLO Token Available via Apple Pay & Credit Card
-
Mama's Creations to Showcase Expanded One-Stop-Shop Product Lineup at IDDBA 2025
-
Mama's Creations to Showcase Expanded One-Stop-Shop Product Lineup at IDDBA 2025
-
Yoshiharu Partners with Good Mood Studio and Wealthrail to Enter U.S. Real Estate Market
-
Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease
-
InterDigital to Present at William Blair 45th Annual Growth Stock Conference
-
Volcon ePowersports Receives Purchase Order from Advanced EV for 1,000 Golf Carts and Resumes Share Repurchase Program
-
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
-
GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025
-
GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects
-
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives
-
Vemanti Group Announces Executive Leadership Appointment
-
NANO Nuclear Energy Announces Pricing of $105 Million Private Placement of Common Stock
-
SEALSQ Invests in Wecan Token to Advance Post-Quantum Digital Identity and Strengthen Blockchain Security, following a Strategic Partnership with SOLANA
-
Indonesia Energy Provides Update on Operations and Reserves and Planned Drilling During the Remainder of 2025
-
Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis
-
Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time
-
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
-
Siebert Financial Corp. Announces Preliminary Inclusion in the Russell Index
-
Zeo Energy Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
-
GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025
-
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
-
Eaziya Expands CRM Tool Offering, Launches Tiered Pricing Plans for Broker Flexibility
-
Strongline returns to market, signs deal with QLog to ensure leading staff duress offering is available to health systems around the country
-
M4Markets Boosts Social Media Presence, Brings Real-Time Market Insights for Traders Globally
-
TopFX Celebrates 15 Years of Growth in Trading and Liquidity Services
-
Bion Announces First Offtake Commitments for its Organic Nitrogen Fertilizer
-
ZenaTech Provides Quantum Computing Update on ‘Clear Sky' Weather Forecasting Project─AI Drone Swarms to Combat Steep Rise in Billion Dollar Extreme Weather Events
-
KULR Technology Group Set to Join Russell 3000® Index
-
FLUENT Corp. to Report First Quarter 2025 Financial Results on May 29, 2025
-
ZenaTech Provides Quantum Computing Update on ‘Clear Sky' Weather Forecasting Project─AI Drone Swarms to Combat Steep Rise in Billion Dollar Extreme Weather Events
-
Ocean Power Technologies Earns “Trusted Operator” Status in New AUVSI Maritime Certification Program
-
BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
-
Breaking News: Rasool Rezvani (RZ) Named Among the Most Influential Crypto Figures of 2025
-
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
-
Inseego Selected for Preliminary Inclusion in the Russell 2000® Index
-
Bridger Aerospace Announces Signing of Sale Leaseback Transaction for its Headquarters Campus; Strengthening Balance Sheet and Reducing Annual Interest Expense
-
StepStone Group to Present at the Morgan Stanley US Financials Conference
-
IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025
-
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
-
Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary
-
Days Inns - Canada Strengthens Three-Year Partnership with Food Banks Canada Through “After the Bell” Program
-
Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement
-
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated wit
-
America’s Car-Mart Kicks Off Annual Community Fan Drive
-
GridCARE Launches with a Mission to Eliminate AI’s Biggest Bottleneck: Immediate Access to Power
-
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
-
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
-
CanadianSME Small Business Show 2025: Thriving in the Digital-First Economy
